APA (7th ed.) Citation

MP, H., & AA, A. (2024). Rarity & Risk of Secondary Hematologic Neoplasms after CAR T-cell Therapies. Transplantation and cellular therapy, 30(10), 936. https://doi.org/10.1016/j.jtct.2024.09.002

Chicago Style (17th ed.) Citation

MP, Hamilton, and Alizadeh AA. "Rarity & Risk of Secondary Hematologic Neoplasms After CAR T-cell Therapies." Transplantation and Cellular Therapy 30, no. 10 (2024): 936. https://doi.org/10.1016/j.jtct.2024.09.002.

MLA (9th ed.) Citation

MP, Hamilton, and Alizadeh AA. "Rarity & Risk of Secondary Hematologic Neoplasms After CAR T-cell Therapies." Transplantation and Cellular Therapy, vol. 30, no. 10, 2024, p. 936, https://doi.org/10.1016/j.jtct.2024.09.002.